1
|
The myofibroblast: one function, multiple origins.
|
Am J Pathol
|
2007
|
8.64
|
2
|
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
|
J Exp Med
|
2010
|
4.71
|
3
|
Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.
|
Am J Pathol
|
2012
|
4.13
|
4
|
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
|
Nat Med
|
2009
|
4.05
|
5
|
CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.
|
Am J Pathol
|
2005
|
4.02
|
6
|
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.
|
Sci Transl Med
|
2014
|
3.23
|
7
|
miR-29 is a major regulator of genes associated with pulmonary fibrosis.
|
Am J Respir Cell Mol Biol
|
2010
|
2.87
|
8
|
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype.
|
J Proteome Res
|
2006
|
2.43
|
9
|
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.
|
Am J Respir Crit Care Med
|
2003
|
2.35
|
10
|
Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.
|
Cell Signal
|
2006
|
2.22
|
11
|
Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2009
|
2.15
|
12
|
Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.
|
Am J Respir Cell Mol Biol
|
2003
|
2.14
|
13
|
Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor.
|
J Biol Chem
|
2003
|
2.12
|
14
|
Host responses in tissue repair and fibrosis.
|
Annu Rev Pathol
|
2012
|
2.10
|
15
|
Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts.
|
FASEB J
|
2005
|
2.09
|
16
|
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.
|
Drugs
|
2004
|
2.05
|
17
|
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?
|
Am J Respir Crit Care Med
|
2007
|
1.94
|
18
|
Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury.
|
Am J Pathol
|
2005
|
1.93
|
19
|
A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury.
|
Crit Care Med
|
2012
|
1.92
|
20
|
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.
|
J Clin Invest
|
2007
|
1.87
|
21
|
Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.
|
J Clin Invest
|
2013
|
1.81
|
22
|
Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10.
|
Am J Respir Crit Care Med
|
2003
|
1.75
|
23
|
PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
|
Am J Physiol Lung Cell Mol Physiol
|
2007
|
1.74
|
24
|
Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.
|
J Pathol
|
2003
|
1.71
|
25
|
Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction.
|
Am J Respir Cell Mol Biol
|
2012
|
1.67
|
26
|
Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells.
|
Antioxid Redox Signal
|
2009
|
1.64
|
27
|
Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling.
|
Free Radic Biol Med
|
2011
|
1.56
|
28
|
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.
|
Am J Respir Crit Care Med
|
2014
|
1.54
|
29
|
Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.
|
Oncogene
|
2004
|
1.50
|
30
|
Altered DNA methylation profile in idiopathic pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2012
|
1.47
|
31
|
Participation of miR-200 in pulmonary fibrosis.
|
Am J Pathol
|
2011
|
1.43
|
32
|
Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways.
|
FASEB J
|
2009
|
1.41
|
33
|
Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts.
|
J Biol Chem
|
2010
|
1.36
|
34
|
NOX enzymes and pulmonary disease.
|
Antioxid Redox Signal
|
2009
|
1.29
|
35
|
Constitutive activation of prosurvival signaling in alveolar mesenchymal cells isolated from patients with nonresolving acute respiratory distress syndrome.
|
Am J Physiol Lung Cell Mol Physiol
|
2005
|
1.23
|
36
|
Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.
|
Am J Respir Cell Mol Biol
|
2009
|
1.20
|
37
|
Transforming growth factor beta1 induces alphavbeta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway.
|
J Biol Chem
|
2008
|
1.20
|
38
|
Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis.
|
Am J Respir Cell Mol Biol
|
2007
|
1.20
|
39
|
PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling.
|
Am J Physiol Lung Cell Mol Physiol
|
2007
|
1.19
|
40
|
Lung cells from neonates show a mesenchymal stem cell phenotype.
|
Am J Respir Crit Care Med
|
2007
|
1.18
|
41
|
HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.
|
Am J Physiol Lung Cell Mol Physiol
|
2013
|
1.17
|
42
|
miR-145 regulates myofibroblast differentiation and lung fibrosis.
|
FASEB J
|
2013
|
1.15
|
43
|
Fibrosis: ultimate and proximate causes.
|
J Clin Invest
|
2014
|
1.15
|
44
|
Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection.
|
Am J Respir Crit Care Med
|
2004
|
1.12
|
45
|
Extracorporeal membrane oxygenation for acute respiratory failure in adults: the need for pulmonary INTERMACS.
|
Am J Respir Crit Care Med
|
2014
|
1.07
|
46
|
STAT4 is a critical mediator of early innate immune responses against pulmonary Klebsiella infection.
|
J Immunol
|
2004
|
1.06
|
47
|
Oxygen in the evolution of complex life and the price we pay.
|
Am J Respir Cell Mol Biol
|
2008
|
1.05
|
48
|
Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.
|
Am J Respir Crit Care Med
|
2008
|
1.05
|
49
|
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.
|
Drugs
|
2011
|
1.03
|
50
|
Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
|
Cancer Res
|
2005
|
1.03
|
51
|
Idiopathic pulmonary fibrosis: a disorder of lung regeneration?
|
Am J Respir Crit Care Med
|
2008
|
1.02
|
52
|
Reversible differentiation of myofibroblasts by MyoD.
|
Exp Cell Res
|
2011
|
1.02
|
53
|
Toll-like receptor 4 engagement inhibits adenosine 5'-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism.
|
Mol Med
|
2012
|
1.01
|
54
|
Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice.
|
Am J Respir Cell Mol Biol
|
2012
|
1.00
|
55
|
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
|
J Pharmacol Exp Ther
|
2007
|
1.00
|
56
|
Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-gamma ligands.
|
Am J Physiol Lung Cell Mol Physiol
|
2003
|
0.99
|
57
|
Epithelial-mesenchymal interactions in pulmonary fibrosis.
|
Semin Respir Crit Care Med
|
2006
|
0.99
|
58
|
Retracted
miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis.
|
FASEB J
|
2012
|
0.99
|
59
|
Histone modifications in senescence-associated resistance to apoptosis by oxidative stress.
|
Redox Biol
|
2013
|
0.98
|
60
|
Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
|
Eur Respir J
|
2014
|
0.97
|
61
|
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways.
|
Cancer Res
|
2013
|
0.96
|
62
|
Microbicidal activity of vascular peroxidase 1 in human plasma via generation of hypochlorous acid.
|
Infect Immun
|
2012
|
0.95
|
63
|
Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis.
|
FASEB J
|
2013
|
0.93
|
64
|
Relaxin regulates myofibroblast contractility and protects against lung fibrosis.
|
Am J Pathol
|
2011
|
0.93
|
65
|
Neuronal Wiskott-Aldrich syndrome protein (N-WASP) is critical for formation of α-smooth muscle actin filaments during myofibroblast differentiation.
|
Am J Physiol Lung Cell Mol Physiol
|
2012
|
0.92
|
66
|
Targeting NOX enzymes in pulmonary fibrosis.
|
Cell Mol Life Sci
|
2012
|
0.92
|
67
|
Development and maintenance of a biospecimen repository for clinical samples derived from pulmonary patients.
|
Clin Transl Sci
|
2014
|
0.91
|
68
|
Challenges in translating preclinical studies to effective drug therapies in idiopathic pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2010
|
0.91
|
69
|
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.
|
Treat Respir Med
|
2006
|
0.90
|
70
|
Innovative approaches to the therapy of fibrosis.
|
Curr Opin Rheumatol
|
2009
|
0.88
|
71
|
Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury.
|
Am J Pathol
|
2013
|
0.87
|
72
|
Caveolin-1 regulates dorsoventral patterning through direct interaction with beta-catenin in zebrafish.
|
Dev Biol
|
2010
|
0.86
|
73
|
Vascular peroxidase-1 is rapidly secreted, circulates in plasma, and supports dityrosine cross-linking reactions.
|
Free Radic Biol Med
|
2011
|
0.86
|
74
|
Vascular peroxidase 1 catalyzes the formation of hypohalous acids: characterization of its substrate specificity and enzymatic properties.
|
Free Radic Biol Med
|
2012
|
0.85
|
75
|
Heritability of pulmonary function estimated from pedigree and whole-genome markers.
|
Front Genet
|
2013
|
0.85
|
76
|
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
|
Curr Med Chem
|
2008
|
0.85
|
77
|
Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010.
|
Proc Am Thorac Soc
|
2011
|
0.83
|
78
|
Elevated levels of NO are localized to distal airways in asthma.
|
Free Radic Biol Med
|
2011
|
0.82
|
79
|
Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
|
Int J Mol Sci
|
2013
|
0.82
|
80
|
Update in diffuse parenchymal lung disease 2008.
|
Am J Respir Crit Care Med
|
2009
|
0.81
|
81
|
Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophages.
|
J Immunol
|
2013
|
0.81
|
82
|
Current and emerging drugs for idiopathic pulmonary fibrosis.
|
Expert Opin Emerg Drugs
|
2007
|
0.81
|
83
|
NADPH oxidases in lung health and disease.
|
Antioxid Redox Signal
|
2014
|
0.81
|
84
|
Nonresolving fibrotic disorders: idiopathic pulmonary fibrosis as a paradigm of impaired tissue regeneration.
|
Am J Med Sci
|
2011
|
0.81
|
85
|
The code of non-coding RNAs in lung fibrosis.
|
Cell Mol Life Sci
|
2015
|
0.80
|
86
|
The paradox of reactive oxygen species: injury, signaling, or both?
|
Am J Physiol Lung Cell Mol Physiol
|
2003
|
0.80
|
87
|
Classification of interstitial pneumonias: what do gene expression profiles tell us?
|
Am J Respir Crit Care Med
|
2006
|
0.79
|
88
|
Wnt/β-catenin and transforming growth factor-β signaling in pulmonary fibrosis. A case for antagonistic pleiotropy?
|
Am J Respir Crit Care Med
|
2014
|
0.78
|
89
|
Mesenchymal cell fate and phenotypes in the pathogenesis of emphysema.
|
COPD
|
2009
|
0.78
|
90
|
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.
|
Am J Respir Cell Mol Biol
|
2017
|
0.77
|
91
|
Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
|
Curr Opin Rheumatol
|
2015
|
0.77
|
92
|
Use of ECMO in the Management of Severe Acute Respiratory Distress Syndrome: A Survey of Academic Medical Centers in the United States.
|
ASAIO J
|
2015
|
0.76
|
93
|
Update in diffuse parenchymal lung disease 2011.
|
Am J Respir Crit Care Med
|
2012
|
0.76
|
94
|
Lactate, a novel trigger of transforming growth factor-β activation in idiopathic pulmonary fibrosis.
|
Am J Respir Crit Care Med
|
2012
|
0.76
|
95
|
Biological insights from clinical trials and networks.
|
Am J Respir Crit Care Med
|
2012
|
0.75
|
96
|
3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.
|
JCI Insight
|
2017
|
0.75
|